NYSE:QGENLife Sciences
Qiagen (NYSE:QGEN) Margin Recovery Challenges Bearish Narratives After 413.6% Earnings Growth
Qiagen (NYSE:QGEN) reported a sharp turnaround in profitability this quarter, with net profit margins rising to 18.3% from just 3.7% a year ago. Earnings growth surged by 413.6% over the past twelve months. Despite a negative five-year trend, earnings are now forecast to increase at 11.5% per year. This forecast is below the broader US market’s expected pace. Investors will note that Qiagen shares are trading at $44.05, representing a discount to the estimated fair value and pricing in...